MANGANESE SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Manganese Sulfate patents expire, and when can generic versions of Manganese Sulfate launch?
Manganese Sulfate is a drug marketed by Abraxis Pharm and is included in one NDA.
The generic ingredient in MANGANESE SULFATE is manganese sulfate. There are five drug master file entries for this compound. Additional details are available on the manganese sulfate profile page.
Summary for MANGANESE SULFATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MANGANESE SULFATE at DailyMed |
Recent Clinical Trials for MANGANESE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medesis Pharma SA | Phase 1/Phase 2 |
Dow University of Health Sciences | Phase 3 |
National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
US Patents and Regulatory Information for MANGANESE SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abraxis Pharm | MANGANESE SULFATE | manganese sulfate | INJECTABLE;INJECTION | 019228-001 | May 5, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |